ELUT
Elutia Inc.
There isn't enough reported data to score ELUT yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
ELUT Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Weak | |
| Unavailable |
ELUT's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
ELUT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 0.8x | $0.94 | +7.2% |
| Current | 0.8x | $0.88 | — |
| Fair | 1x | $1.18 | +34% |
| Expensive | 1.2x | $1.43 | +62% |
Historical ranges are pointers, not guarantees.
ELUT has the edge over UNH in the historical PE scenario, which offers more potential upside but is not a forecast.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
ELUT Forward outlook
There aren't enough analyst estimates for ELUT to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
ELUT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.15 | +$2.07 |
| Q2 2026 | $1.00 | +$2.06 |
| Q1 2026 | $0.91 | +$2.84 |
| Q4 2025 | $0.87 | +$3.34 |
| Q3 2025 | -$0.92 | +$1.65 |
| Q2 2025 | -$1.06 | +$1.75 |
| Q1 2025 | -$1.93 | +$0.40 |
| Q4 2024 | -$2.47 | -$0.40 |
ELUT has the edge over UNH on earnings, with more consistent year-over-year improvement.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
ELUT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1M | -66% |
| Q2 2026 | $2.4M | -61% |
| Q1 2026 | $3.1M | -48% |
| Q4 2025 | $3.3M | -40% |
| Q3 2025 | $3.3M | -44% |
| Q2 2025 | $6.3M | -0.4% |
| Q1 2025 | $6M | -9.9% |
| Q4 2024 | $5.5M | -6.9% |
ELUT's revenue has slid since its 2023 peak: $1M last quarter, down 66% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -607% | -450 points |
| Q2 2026 | -328% | -170 points |
| Q1 2026 | -204% | -73 points |
| Q4 2025 | -201% | -46 points |
| Q3 2025 | -157% | +16 points |
| Q2 2025 | -158% | -22 points |
| Q1 2025 | -131% | -4.7 points |
| Q4 2024 | -154% | -9.4 points |
ELUT's operating margin was −607% last quarter, down 450 points from the same quarter a year ago, near the bottom of its range since 2020.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over ELUT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over ELUT on profitability, with a higher operating margin.
ELUT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$8.2M | -$4.7M |
| Q2 2026 | -$8.6M | -$210K |
| Q1 2026 | -$8.3M | +$869K |
| Q4 2025 | -$25.7M | -$13.3M |
| Q3 2025 | -$3.5M | +$457K |
| Q2 2025 | -$8.3M | -$4M |
| Q1 2025 | -$9.2M | -$6.5M |
| Q4 2024 | -$12.4M | -$3.3M |
ELUT has burned cash in almost every quarter: −$51M over the past year, against −$33M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over ELUT on cash generation, producing positive trailing cash flow while its opponent burns cash.
ELUT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.5% | +3.3M shares |
| 1 year | +1.2% | +581K shares |
| 3 years | +179% | +30.5M shares |
| 5 years | +364% | +37.3M shares |
ELUT has 48M diluted shares, up 1.2% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over ELUT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
ELUT Net Leverage
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
ELUT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.8 | Neutral |
| Stochastic | 47.7 | Neutral |
ELUT's weekly RSI is 48 (neutral) and its Stochastic is 48 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
ELUT PE vs Healthcare Sector
| Metric | ELUT | Sector median | Relative |
|---|---|---|---|
| PE | 0.8x | 26x | 97% below |
| PE % | 3 | 33 | 30 pts below |
ELUT has the edge over UNH on valuation relative to its sector.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
ELUT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.83 | 6% above |
| 20 week MA | $0.87 | 1.1% above |
| 50 week MA | $0.93 | 5.4% below |
| 100 week MA | $1.53 | 42% below |
| 200 week MA | $2.24 | 61% below |
ELUT has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 61% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over ELUT on trend strength, trading above more of its moving averages.
ELUT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.5 | $12.6 | -7.2% |
| 2021 | $12.6 | $6.67 | -47% |
| 2022 | $6.67 | $4.10 | -39% |
| 2023 | $4.10 | $2.16 | -47% |
| 2024 | $2.16 | $3.94 | +82% |
| 2025 | $3.94 | $0.54 | -86% |
| 2026 YTD | $0.54 | $0.88 | +63% |
ELUT has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.